Sofia, Bulgaria, July 24, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on July 23, 2025 the Company sold 380 (three hundred eighty) repurchased own shares representing 0.0002% of the share capital of the Company, at a total value of BGN 934.80 on the Bulgarian Stock Exchange, the average price per share was BGN 2.46.

Sofia, Bulgaria, July 23, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on July 22, 2025 the Company sold 11 000 (eleven thousand) repurchased own shares representing 0.01% of the share capital of the Company, at a total value of BGN 27 500.00 on the Bulgarian Stock Exchange, the average price per share was BGN 2.50.

Sofia, Bulgaria, July 21, 2025 – According to the requirements of Art. 100t of the Law on Public Offering of Securities (LPOS), “Sopharma” AD (SFA: “Bulgarian Stock Exchange” AD, SPH: Warsaw Stock Exchange) notifies, that for June 2025 the Company recorded increase in sales of 49% compared to the same month of the previous year, incl. 5% increase in domestic sales and 92% increase in export sales due to the uneven recovery of sales оn the main export markets.

Sofia, Bulgaria, July 21, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on July 18, 2025 the Company sold 81 170 (eighty-one thousand one hundred seventy) repurchased own shares representing 0.05% of the share capital of the Company, at a total value of BGN 203 088.00 on the Bulgarian Stock Exchange, the average price per share was BGN 2.50.